Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World Setting.
Gendron N, Chocron R, Billoir P, Brunier J, Camoin-Jau L, Tuffigo M, Faille D, Teissandier D, Gay J, de Raucourt E, Suner L, Bonnet C, Martin AC, Lasne D, Ladhari C, Lebreton A, Bertoletti L, Ajzenberg N, Gaussem P, Morange PE, Le Cam Duchez V, Viallon A, Roy PM, Lillo-le Louët A, Smadja DM.
Gendron N, et al. Among authors: teissandier d.
Front Med (Lausanne). 2020 Dec 16;7:599626. doi: 10.3389/fmed.2020.599626. eCollection 2020.
Front Med (Lausanne). 2020.
PMID: 33392223
Free PMC article.